Brief: Guard Therapeutics International Q2 Loss Up To SEK 32.2 Mln
Aug 21 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST: GUARD THERAPEUTICS INTERNATIONAL: Q2 LOSS OF KSEK -32,221 (-23,874) GUARD THERAPEUTICS INTERNATIONAL: Q2 EARNINGS PER SHARE SEK -1.66 (-2.33) Source text: ID:nMFNc3H0KD Further company coverage: GUARD.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover